Jazz Pharmaceuticals (JAZZ) Change in Cash (2010 - 2026)

Jazz Pharmaceuticals has reported Change in Cash for 17 years, with the latest figure at $452.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 182.11% year-over-year to $452.4 million; the trailing twelve-month figure through Mar 2026 stood at -$17.6 million (down 104.2% YoY), and the FY2025 full-year result was -$1.0 billion, down 212.62% from the prior year.
• Change in Cash for Q1 2026 stood at $452.4 million, up from $65.8 million in the prior quarter.
• The five-year high for Change in Cash was $862.3 million in Q3 2024, with the low at -$672.0 million in Q2 2025.
• Average Change in Cash over 5 years is $73.7 million, with a median of $114.4 million recorded in 2023.
• Year-over-year, Change in Cash soared 1515.28% in 2024 and sank 775.65% in 2025.
• Tracing JAZZ's Change in Cash over 5 years: stood at $42.1 million in 2022, then soared by 305.04% to $170.6 million in 2023, then rose by 14.13% to $194.7 million in 2024, then slumped by 66.19% to $65.8 million in 2025, then soared by 587.24% to $452.4 million in 2026.
• The last three Change in Cash figures came in at $452.4 million (Q1 2026), $65.8 million (Q4 2025), and $136.2 million (Q3 2025), per Business Quant data.

Peer Comparison